<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Molecular modeling, virtual screening and other computational techniques are widely used methods to understand the phylogenetics, molecular aspects of proteins and protein-ligand interactions during drug discovery process [
 <xref rid="bb0070" ref-type="bibr">[14]</xref>, 
 <xref rid="bb0075" ref-type="bibr">[15]</xref>, 
 <xref rid="bb0080" ref-type="bibr">[16]</xref>, 
 <xref rid="bb0085" ref-type="bibr">[17]</xref>, 
 <xref rid="bb0090" ref-type="bibr">[18]</xref>]. Virtual screening has been used in drug discovery against emerging and fatal diseases including SARS CoV proteases [
 <xref rid="bb0095" ref-type="bibr">19</xref>,
 <xref rid="bb0100" ref-type="bibr">20</xref>], Hepatitis C virus RNA-dependent RNA polymerase [
 <xref rid="bb0105" ref-type="bibr">21</xref>], dengue virus [
 <xref rid="bb0110" ref-type="bibr">22</xref>] and Ebola virus [
 <xref rid="bb0115" ref-type="bibr">23</xref>].
</p>
